State Street Corp Chembio Diagnostics, Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.45 - $0.8 $1,125 - $2,000	2,500 Added 4.91%	53,409 $35,000
Q3 2021 Nov 15, 2021	SELL	$2.06 - $5.34 $84,872 - $220,008	-41,200 Reduced 44.73%	50,909 $127,000
Q2 2021 Aug 16, 2021	SELL	$2.88 - $5.64 $558,060 - $1.09 Million	-193,771 Reduced 67.78%	92,109 $274,000
Q1 2021 May 17, 2021	BUY	$3.4 - $7.97 $113,900 - $266,995	33,500 Added 13.27%	285,880 $1 Million
Q4 2020 Feb 16, 2021	SELL	$4.11 - $7.51 $7,093 - $12,962	-1,726 Reduced 0.68%	252,380 $1.2 Million
Q3 2020 Nov 10, 2020	BUY	$3.28 - $5.93 $247,823 - $448,047	75,556 Added 42.32%	254,106 $1.24 Million
Q2 2020 Aug 14, 2020	BUY	$3.18 - $15.54 $567,789 - $2.77 Million	178,550 New	178,550 $580,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.